1820 McCarthy Blvd.
Milpitas , CA 95035
USA
Product Categories:
Embolic Protection Devices, Stents, Stents Bare Metal, Stents Carotid, Stents Drug Eluting, Vascular Access, Vascular Closure Devices
Embolic Protection Devices, Stents, Stents Bare Metal, Stents Carotid, Stents Drug Eluting, Vascular Access, Vascular Closure Devices
Cordis, a Cardinal Health company, is a worldwide leader in the development and manufacture of interventional vascular technology with a more than 50-year history of delivering pioneering products to treat millions of patients.
Related Content
April 9, 2010 โ The first patients have been enrolled in the INNOVATION trial, which will assess the safety of a new ...
April 09, 2010
March 30, 2010 โ A new coronary stent recently launched in Europe is designed to gain easier access to distal lesions ...
March 30, 2010February 1, 2010 โ Three patent disputes between Boston Scientific Corp. and Johnson & Johnson (J&J) were settled today ...
February 01, 2010
November 10, 2009 โ Clinically, stent fracture has been reported in 1-2 percent of patients after drug-eluting stent ...
November 10, 2009November 4, 2009 โ Cordis and FDA notified healthcare professionals this week of a nationwide recall of all lots of the ...
November 04, 2009September 29, 2009 โ Cordis Corp. and Boston Scientific announced late today they reached an agreement to resolve ...
September 29, 2009
September 1, 2009 โ Cordis Corp. said first patient has been enrolled in the CYPRESS study, which will assess clinical ...
September 01, 2009
March 16, 2009 - Cordis Corp. said today it plans to launch a global, head-to-head, randomized clinical trial called ...
March 16, 2009
February 16 - The CYPHER SELECT Plus Sirolimus-eluting Coronary Stent has received CE marking within the European Union ...
February 16, 2009August 28, 2008 โ In patients with diabetes, the CYPHER Sirolimus-eluting coronary stent outperformed the Taxus stent ...
August 27, 2008